NanoVation will receive $600m in upfront cash and potential milestone payments, ...
Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for t...
The Outsourcing in Clinical Trials New England conference will gather pharma exp...
MaxCyte has entered into a license agreement with Kamau Therapeutics, a clinical...
Sanofi has commenced the shipping of BEYFORTUS to the US for healthcare provider...
The SBTi has validated and approved India's Piramal Pharma’s near-term greenhous...
Drones are starting to play a vital role in the clinical supply chain across sub...
BMS paid $150m upfront to enter a collaborative development deal for bispecific ...
Poseida Therapeutics has received RMAT designation from the US FDA for its CAR-T...
The company claims that the FTC’s July 2024 report is riddled with “false and mi...
The clinical hold was placed on three studies investigating azenosertib in June ...
The partnership will see AI-enabled screening used to address bioavailability is...
Bicara was one of three biotechs that went public last week in one of the busies...
Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating ato...
The published belrestotug/dostarlimab data is still too immature to prove the co...
